<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ren X</submitter><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>National Science Foundation</funding><pagination>8550-8556</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9337741</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(29)</volume><pubmed_abstract>Organophosphonate compounds have represented a rich source of biologically active compounds, including enzyme inhibitors, antibiotics, and antimalarial agents. Here, we report the development of a highly stereoselective strategy for olefin cyclopropanation in the presence of a phosphonyl diazo reagent as carbene precursor. In combination with a 'substrate walking' protein engineering strategy, two sets of efficient and enantiodivergent myoglobin-based biocatalysts were developed for the synthesis of both (1&lt;i>R&lt;/i>,2&lt;i>S&lt;/i>) and (1&lt;i>S&lt;/i>,2&lt;i>R&lt;/i>) enantiomeric forms of the desired cyclopropylphosphonate ester products. This methodology enables the efficient transformation of a broad range of vinylarene substrates at a preparative scale (&lt;i>i.e.&lt;/i> gram scale) with up to 99% de and ee. Mechanistic studies provide insights into factors that contribute to make this reaction inherently more challenging than hemoprotein-catalyzed olefin cyclopropanation with ethyl diazoacetate investigated previously. This work expands the range of synthetically useful, enzyme-catalyzed transformations and paves the way to the development of metalloprotein catalysts for abiological carbene transfer reactions involving non-canonical carbene donor reagents.</pubmed_abstract><journal>Chemical science</journal><pubmed_title>Highly stereoselective and enantiodivergent synthesis of cyclopropylphosphonates with engineered carbene transferases.</pubmed_title><pmcid>PMC9337741</pmcid><funding_grant_id>CHE-0946653</funding_grant_id><funding_grant_id>S10OD030302</funding_grant_id><funding_grant_id>S10 OD025242</funding_grant_id><funding_grant_id>GM098628</funding_grant_id><funding_grant_id>CHE-1725028</funding_grant_id><funding_grant_id>R01 GM098628</funding_grant_id><funding_grant_id>S10 OD030302</funding_grant_id><funding_grant_id>CBET-1929256</funding_grant_id><funding_grant_id>CBET 1929237</funding_grant_id><pubmed_authors>Ren X</pubmed_authors><pubmed_authors>Khare SD</pubmed_authors><pubmed_authors>Shen Z</pubmed_authors><pubmed_authors>Chandgude AL</pubmed_authors><pubmed_authors>Fasan R</pubmed_authors><pubmed_authors>Carminati DM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Highly stereoselective and enantiodivergent synthesis of cyclopropylphosphonates with engineered carbene transferases.</name><description>Organophosphonate compounds have represented a rich source of biologically active compounds, including enzyme inhibitors, antibiotics, and antimalarial agents. Here, we report the development of a highly stereoselective strategy for olefin cyclopropanation in the presence of a phosphonyl diazo reagent as carbene precursor. In combination with a 'substrate walking' protein engineering strategy, two sets of efficient and enantiodivergent myoglobin-based biocatalysts were developed for the synthesis of both (1&lt;i>R&lt;/i>,2&lt;i>S&lt;/i>) and (1&lt;i>S&lt;/i>,2&lt;i>R&lt;/i>) enantiomeric forms of the desired cyclopropylphosphonate ester products. This methodology enables the efficient transformation of a broad range of vinylarene substrates at a preparative scale (&lt;i>i.e.&lt;/i> gram scale) with up to 99% de and ee. Mechanistic studies provide insights into factors that contribute to make this reaction inherently more challenging than hemoprotein-catalyzed olefin cyclopropanation with ethyl diazoacetate investigated previously. This work expands the range of synthetically useful, enzyme-catalyzed transformations and paves the way to the development of metalloprotein catalysts for abiological carbene transfer reactions involving non-canonical carbene donor reagents.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2025-06-01T01:57:39.355Z</modification><creation>2024-11-14T15:34:13.672Z</creation></dates><accession>S-EPMC9337741</accession><cross_references><pubmed>35974764</pubmed><doi>10.1039/d2sc01965e</doi></cross_references></HashMap>